Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Entheon Biomedical Corp (OP:ENTBF)

0.0794 UNCHANGED
Last Price Updated: 3:29 PM EST, Dec 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0794
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0794
Today's Range 0.0794 - 0.0794
52wk Range 0.0470 - 0.2880
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them ↗
The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business... 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate Its CYB004 Clinical Development Program
Via Investor Brand Network

Performance

YTD
N/A
N/A
1 Month
-12.9%
-12.9%
3 Month
+53.9%
+53.9%
6 Month
-6.0%
-6.0%
1 Year
-61.2%
-61.2%

More News

Read More
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study Expected to Accelerate Clinical Development Path of CYB004
Via Investor Brand Network
News headline image
Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill ↗
Via Benzinga
News headline image
Largest Phase-1 DMT Study In The Netherlands, A Collaboration Between Entheon & Cybin ↗
Via Benzinga
News headline image
Ehave Partners With Halugen Life Sciences To Create A Ketamine Precision Medicine Platform For Clinical Research ↗
Via Benzinga
News headline image
Entheon Biomedical Announces Non-Brokered Private Placement Financing ↗
Via Benzinga
News headline image
Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th ↗
Via Benzinga
News headline image
Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins ↗
Via Benzinga
News headline image
Psychedelics Biotech Startup Launches Phase 1 Study On Ayahuasca's Active Ingredient ↗
Via Benzinga
News headline image
Entheon Biomedical Reports Launching Multiple Studies to Advance Psychedelic-Based Mental Health Treatments ↗
Via Benzinga
Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) Featured in Virtual Coverage of Benzinga’s Small Cap Conference
Via Investor Brand Network
News headline image
Compass Pathways 2.0: A New Rally In Psychedelic Stocks? ↗
Via Talk Markets
Topics Initial Public Offering
News headline image
Entheon Biomedical Provides Corporate Update on Studies and Clinical Trials
Via Newsfile
News headline image
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation ↗
Via Benzinga
News headline image
Entheon Biomedical Acquires Lobo Genetics, Inc. in Bid to Strengthen Screening and Treatment Evaluation Tech for Psychedelics ↗
Via Benzinga
News headline image
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are ↗
Via Benzinga
News headline image
Clinical Director of Imperial College's Center for Psychedelic Research Joins Entheon Advisory Board
Via Newsfile
News headline image
Entheon Biomedical Corp. Announces DTC Eligibility
Via Newsfile
News headline image
CORRECTION FROM SOURCE: BTV Examines the Rapidly Expanding Psychedelics Market
Via Newsfile
News headline image
BTV Examines the Rapidly Expanding Psychedelics Market
Via Newsfile
News headline image
Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess the Electroneurophysiologic Effects of Ketamine
Via Newsfile
News headline image
Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected ↗
Via Benzinga
News headline image
Entheon Biomedical Corp. Strengthens Its Psychedelic-Assisted Protocols Through Acquisition Of Lobo Genetics ↗
Via Benzinga
News headline image
Entheon Biomedical Corp. Acquires Lobo Genetics Inc.
Via Newsfile
Topics Cannabis

Frequently Asked Questions

Is Entheon Biomedical Corp publicly traded?
Yes, Entheon Biomedical Corp is publicly traded.
What exchange does Entheon Biomedical Corp trade on?
Entheon Biomedical Corp trades on the OTC Traded
What is the ticker symbol for Entheon Biomedical Corp?
The ticker symbol for Entheon Biomedical Corp is ENTBF on the OTC Traded
What is the current price of Entheon Biomedical Corp?
The current price of Entheon Biomedical Corp is 0.0794
When was Entheon Biomedical Corp last traded?
The last trade of Entheon Biomedical Corp was at 12/18/25 03:29 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.